30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

INmune Bio Inc (INMB)

Track

The most recent insider trading activity occurred on September 30, 2024, with a BUY transaction by the Chief Financial Officer. Prior to this, significant BUY transactions were made by the President and CEO and the CFO in September 2024. Earlier transactions in 2024 and 2023 also show a pattern of insider BUYs.
Stock chart
Ticker: INMB Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Moss David J
Chief Financial Officer
1 purchase — total 52,868 USD
Buy 30 Sep 2024
Value US$4,947,490.93 | Price 35.26 | Shares 75,011
Buy 12 Sep 2024
Value US$4,584,282.50 | Price 98.31 | Shares 82,453
Buy 12 Sep 2024
Value US$49,023.75 | Price 6.38 | Shares 7,690
Buy 25 Jun 2024
Value US$36,350.00 | Price 7.27 | Shares 5,000
Buy 10 Nov 2023
Value US$48,650.00 | Price 6.95 | Shares 7,000
Planned sale 12 Jul 2023
Value US$110,085.00 | Price 11.01 | Shares 10,000
Proposed sale 12 Jul 2023
Value US$960,085.00 | Price 16.00 | Shares 60,000
Buy 17 Mar 2023
Value US$16,062.50 | Price 6.43 | Shares 2,500
Buy 27 May 2022
Value US$20,370.00 | Price 6.79 | Shares 3,000
Buy 26 May 2022
Value US$48,279.00 | Price 6.27 | Shares 7,700
Buy 26 May 2022
Value US$40,383.00 | Price 6.41 | Shares 6,300
Buy 17 Nov 2021
Value US$33,875.00 | Price 13.55 | Shares 2,500
Planned sale 3 Nov 2021
Value US$14,020.00 | Price 20.00 | Shares 701
Planned sale 3 Nov 2021
Value US$72,520.00 | Price 20.00 | Shares 3,626
Planned sale 3 Nov 2021
Value US$20,500.00 | Price 20.00 | Shares 1,025
Planned sale 27 Oct 2021
Value US$130,340.00 | Price 20.00 | Shares 6,517
Planned sale 27 Oct 2021
Value US$47,140.00 | Price 20.00 | Shares 2,357
Planned sale 27 Oct 2021
Value US$41,580.00 | Price 20.00 | Shares 2,079
Planned sale 25 Oct 2021
Value US$260.00 | Price 20.00 | Shares 13
Planned sale 22 Oct 2021
Value US$22,840.00 | Price 20.00 | Shares 1,142
Planned sale 22 Oct 2021
Value US$8,000.00 | Price 20.00 | Shares 400
Planned sale 22 Oct 2021
Value US$472,320.00 | Price 20.00 | Shares 23,616
Planned sale 8 Jul 2021
Value US$487,588.50 | Price 20.19 | Shares 24,150
Planned sale 7 Jul 2021
Value US$117,117.00 | Price 20.02 | Shares 5,850
Planned sale 14 Jun 2021
Value US$190,200.00 | Price 19.02 | Shares 10,000
Planned sale 31 Mar 2021
Value US$119,496.00 | Price 11.95 | Shares 10,000
Sale 27 Jan 2020
Value US$1,012,000.00 | Price 4.60 | Shares 220,000
Buy 11 Sep 2019
Value US$18,178.56 | Price 6.23 | Shares 2,918
Buy 21 Aug 2019
Value US$15,000.00 | Price 6.00 | Shares 2,500
Buy 20 Aug 2019
Value US$15,000.00 | Price 6.00 | Shares 2,500
Buy 20 Aug 2019
Value US$6,030.80 | Price 6.03 | Shares 1,000
Buy 20 Aug 2019
Value US$592.39 | Price 5.92 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$2,124.40 | Price 5.65 | Shares 376
Buy 20 Aug 2019
Value US$1,333.40 | Price 5.65 | Shares 236
Buy 20 Aug 2019
Value US$406.80 | Price 5.65 | Shares 72
Buy 20 Aug 2019
Value US$11,300.00 | Price 5.65 | Shares 2,000
Buy 20 Aug 2019
Value US$1,350.35 | Price 5.65 | Shares 239
Buy 20 Aug 2019
Value US$435.05 | Price 5.65 | Shares 77
Buy 9 Aug 2019
Value US$6,909.50 | Price 6.91 | Shares 1,000
Buy 9 Aug 2019
Value US$6,428.79 | Price 7.14 | Shares 900
Buy 9 Aug 2019
Value US$720.00 | Price 7.20 | Shares 100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-30 2024-09-30 B Purchase
3.7
Moss David J

Chief Financial Officer

Officer Large shareholder
75,011 -7.4%
35.26
US$4,947,491 		75,011 -7.4% 35.26 US$4,947,491
2024-09-16 2024-09-12 B Purchase
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
82,453 -2.3%
98.31
US$4,584,282 		82,453 -2.3% 98.31 US$4,584,282
2024-09-16 2024-09-12 B Purchase
3.7
Moss David J

Chief Financial Officer

Officer Large shareholder
83,788 -8.7%
440.80
US$4,371,021 		83,788 -8.7% 440.80 US$4,371,021
2024-06-26 2024-06-25 B Purchase
3.2
Juda Scott
Non-Executive Director
5,000 +7.5%
7.27
US$36,350 		5,000 +7.5% 7.27 US$36,350
2023-11-13 2023-11-10 B Purchase
3.2
Juda Scott
Non-Executive Director
7,000 +23.3%
6.95
US$48,650 		7,000 +23.3% 6.95 US$48,650
2023-07-14 2023-07-12 PlS Planned sale
Schroeder Timothy j
Non-Executive Director
10,000 -10.8%
11.01
US$110,085 		10,000 -10.8% 11.01 US$110,085
2023-07-12 2023-07-12 PrS Proposed sale
CTI Holdings, Inc

Director

Non-Executive Director
60,000
16.00
US$960,085 		60,000 16.00 US$960,085
2023-03-20 2023-03-17 B Purchase
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
2,500 +0.2%
6.43
US$16,062 		2,500 +0.2% 6.43 US$16,062
2022-05-31 2022-05-27 B Purchase
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
3,000 +0.2%
6.79
US$20,370 		3,000 +0.2% 6.79 US$20,370
2022-05-31 2022-05-26 B Purchase
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
7,700 +0.6%
6.27
US$48,279 		7,700 +0.6% 6.27 US$48,279
2022-05-31 2022-05-26 B Purchase
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
6,300 +0.4%
6.41
US$40,383 		6,300 +0.4% 6.41 US$40,383
2021-11-17 2021-11-17 B Purchase
3.2
Juda Scott
Non-Executive Director
2,500 +9.1%
13.55
US$33,875 		2,500 +9.1% 13.55 US$33,875
2021-11-04 2021-11-03 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer Large shareholder
701 -0.0%
20.00
US$14,020 		701 -0.0% 20.00 US$14,020
2021-11-04 2021-11-03 PlS Planned sale
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
3,626 -0.2%
20.00
US$72,520 		3,626 -0.2% 20.00 US$72,520
2021-11-04 2021-11-03 PlS Planned sale
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
1,025 -0.1%
20.00
US$20,500 		1,025 -0.1% 20.00 US$20,500
2021-10-29 2021-10-27 PlS Planned sale
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
6,517 -0.4%
20.00
US$130,340 		6,517 -0.4% 20.00 US$130,340
2021-10-29 2021-10-27 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer Large shareholder
2,357 -0.2%
20.00
US$47,140 		2,357 -0.2% 20.00 US$47,140
2021-10-29 2021-10-27 PlS Planned sale
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
2,079 -0.2%
20.00
US$41,580 		2,079 -0.2% 20.00 US$41,580
2021-10-26 2021-10-25 PlS Planned sale
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
13 -0.0%
20.00
US$260 		13 -0.0% 20.00 US$260
2021-10-26 2021-10-22 PlS Planned sale
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
1,142 -0.1%
20.00
US$22,840 		1,142 -0.1% 20.00 US$22,840
2021-10-26 2021-10-22 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer Large shareholder
400 -0.0%
20.00
US$8,000 		400 -0.0% 20.00 US$8,000
2021-10-26 2021-10-22 PlS Planned sale
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
23,616 -1.5%
20.00
US$472,320 		23,616 -1.5% 20.00 US$472,320
2021-07-09 2021-07-08 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer
24,150 -1.6%
20.19
US$487,588 		24,150 -1.6% 20.19 US$487,588
2021-07-09 2021-07-07 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer
5,850 -0.4%
20.02
US$117,117 		5,850 -0.4% 20.02 US$117,117
2021-06-15 2021-06-14 PlS Planned sale
Schroeder Timothy j
Non-Executive Director
10,000 -6.8%
19.02
US$190,200 		10,000 -6.8% 19.02 US$190,200
2021-04-01 2021-03-31 PlS Planned sale
Schroeder Timothy j
Non-Executive Director
10,000 -6.0%
11.95
US$119,496 		10,000 -6.0% 11.95 US$119,496
2020-01-29 2020-01-27 S Sale
0.8
Powers Linda F
Large shareholder
220,000 -51.2%
4.60
US$1,012,000 		220,000 -51.2% 4.60 US$1,012,000
2019-09-12 2019-09-11 B Purchase
0.7
Lowdell Mark William

Chief Scientific Officer

Large shareholder
2,918 +0.2%
6.23
US$18,179 		2,918 +0.2% 6.23 US$18,179
2019-08-22 2019-08-21 B Purchase Juda Scott Non-Executive Director
2,500 +10.0%
6.00
US$15,000 		2,500 +10.0% 6.00 US$15,000
2019-08-22 2019-08-20 B Purchase Juda Scott Non-Executive Director
2,500 +11.1%
6.00
US$15,000 		2,500 +11.1% 6.00 US$15,000
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
1,000 +0.1%
6.03
US$6,031 		1,000 +0.1% 6.03 US$6,031
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.92
US$592 		100 +0.0% 5.92 US$592
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
376 +0.0%
5.65
US$2,124 		376 +0.0% 5.65 US$2,124
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
236 +0.0%
5.65
US$1,333 		236 +0.0% 5.65 US$1,333
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
72 +0.0%
5.65
US$407 		72 +0.0% 5.65 US$407
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
2,000 +0.2%
5.65
US$11,300 		2,000 +0.2% 5.65 US$11,300
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
239 +0.0%
5.65
US$1,350 		239 +0.0% 5.65 US$1,350
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
77 +0.0%
5.65
US$435 		77 +0.0% 5.65 US$435
2019-08-12 2019-08-09 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
1,000 +0.1%
6.91
US$6,910 		1,000 +0.1% 6.91 US$6,910
2019-08-12 2019-08-09 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
900 +0.1%
7.14
US$6,429 		900 +0.1% 7.14 US$6,429
2019-08-12 2019-08-09 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
7.20
US$720 		100 +0.0% 7.20 US$720
Explore more

More insider trading research around INmune Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America